merged_drug-prices-medicare.txt
<question_number>1</question_number>
<answer>The $2,000 annual cap on patient costs for drugs taken at home goes into effect next year (2025), while the new negotiated prices take effect in 2026.</answer>

<question_number>2</question_number>
<answer>The Project 2025 playbook argues that the drug price negotiation program should be repealed, which could weaken or reverse Medicare's new influence on drug prices if former President Donald J. Trump wins the White House in November with full Republican control of Congress.</answer>

<question_number>3</question_number>
<answer>Kamala Harris cast the tiebreaking vote for the legislation that delivered the drug price negotiation program, and she has focused some of her early presidential campaign on the Biden administration's drug pricing reforms, including efforts to "take on Big Pharma" as among her first priorities as president.</answer>

<question_number>4</question_number>
<answer>N/A</answer>

<question_number>5</question_number>
<answer>N/A</answer>

<question_number>6</question_number>
<answer>N/A</answer>

<question_number>7</question_number>
<answer>Enbrel, at $2,355 per month, would require 1 monthly refill before reaching the $2,000 annual cap.</answer>

<question_number>8</question_number>
<answer>N/A</answer>

<question_number>9</question_number>
<answer>Jardiance ($197) and Farxiga ($178) treat the same conditions (diabetes, heart failure and chronic kidney disease), with a difference of $19.</answer>

<question_number>10</question_number>
<answer>N/A</answer>